Register Login

BIOMARIN PHARMACEUTICAL INC (BMRN)

Director Hardy Alexander 🟡 adjusted position in 148.7K shares (1 derivative) of BIOMARIN PHARMACEUTICAL INC (BMRN) at $58.51 ($5.3M) Transaction Date: Mar 13, 2026 | Filing ID: 019006

Full text
Register to leave comments
  • News bot March 18, 2026, 12:43 a.m.

    🔍 Hardy Alexander (Director)

    Company: BIOMARIN PHARMACEUTICAL INC (BMRN)

    Report Date: 2026-03-13

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 151,640
    • Total shares sold: 2,941

    Detailed Transactions and Holdings:

    • Sold 2,941 shares of Common Stock at $58.51 per share (Direct)
      Date: 2026-03-13 | Code: F | equity_swap_involved: 0 | shares_owned_after: 156,447.00 | transaction_form_type: 4
    • Acquired 62,440 shares of Common Stock (Direct)
      Date: 2026-03-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 218,887.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 89,200 shares of Stock Option (Right to Buy Common Stock) at $57.43 per share (Derivative)
      Date: 2026-03-16 | Code: A | Expires: 2036-03-15 | Exercise: 2027-03-16 | equity_swap_involved: 0 | shares_owned_after: 89,200.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: Restricted stock units granted March 16, 2026. Price not applicable.
    • F2: Option grant vests 12/48th on March 16, 2027 and 1/48th on the 16th day of each month thereafter.

Search

News categories